Team:Penn/DrugDeliveryOverview
From 2012.igem.org
(Difference between revisions)
Line 13: | Line 13: | ||
<p style="color:black">Current therapies generally rely on either spatial targeting (targeting within a physical area) or cellular targeting (targeting to a specific antigen or biomarker). </p> | <p style="color:black">Current therapies generally rely on either spatial targeting (targeting within a physical area) or cellular targeting (targeting to a specific antigen or biomarker). </p> | ||
+ | |||
+ | [[File:http://Spatial_Targeting.jpg]] | ||
- | |||
</p> | </p> | ||
Revision as of 23:40, 3 October 2012
Overview
Problems With Current Targeted Therapies
Current therapies generally rely on either spatial targeting (targeting within a physical area) or cellular targeting (targeting to a specific antigen or biomarker).
[[File:http://Spatial_Targeting.jpg]]